Results 1 - 20 of 92,968 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (83,199)
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Dexamethasone should be administered in meningitis in children and adultsLäkartidningen, 2010-12, Vol.107 (49), p.3148-9; discussion 3149 [Peer Reviewed Journal]ISSN: 0023-7205 ;EISSN: 1652-7518 ;PMID: 21280348Full text available |
| 2 |
Material Type: Article
|
|
Forestier disease as unusual cause of dysphagiaLäkartidningen, 1999-04, Vol.96 (16), p.1979-1981 [Peer Reviewed Journal]ISSN: 0023-7205 ;EISSN: 1652-7518 ;PMID: 10330867Full text available |
| 3 |
Material Type: Article
|
|
Perioperative Single Dose Systemic Dexamethasone for Postoperative Pain: A Meta-analysis of Randomized Controlled TrialsAnesthesiology (Philadelphia), 2011-09, Vol.115 (3), p.575-588 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0003-3022 ;EISSN: 1528-1175 ;DOI: 10.1097/ALN.0b013e31822a24c2 ;PMID: 21799397 ;CODEN: ANESAVFull text available |
| 4 |
Material Type: Article
|
|
Dexamethasone in Hospitalized Patients with Covid-19New England Journal of Medicine, 2021-02, Vol.384 (8), p.693-704 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2021436 ;PMID: 32678530Digital Resources/Online E-Resources |
| 5 |
Material Type: Article
|
|
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trialThe lancet oncology, 2021-12, Vol.22 (12), p.1705-1720 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00535-0 ;PMID: 34774221Full text available |
| 6 |
Material Type: Article
|
|
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trialThe Lancet (British edition), 2020-11, Vol.396 (10262), p.1563-1573 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32292-3 ;PMID: 33189178Full text available |
| 7 |
Material Type: Article
|
|
Daratumumab plus Lenalidomide and Dexamethasone for Untreated MyelomaThe New England journal of medicine, 2019-05, Vol.380 (22), p.2104-2115 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1817249 ;PMID: 31141632Full text available |
| 8 |
Material Type: Article
|
|
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 studyThe Lancet (British edition), 2019-12, Vol.394 (10214), p.2096-2107 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)32556-5 ;PMID: 31735560Full text available |
| 9 |
Material Type: Article
|
|
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre studyThe lancet oncology, 2016-01, Vol.17 (1), p.27-38 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 1, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(15)00464-7 ;PMID: 26671818Full text available |
| 10 |
Material Type: Article
|
|
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for MyelomaThe New England journal of medicine, 2017-04, Vol.376 (14), p.1311-1320 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611750 ;PMID: 28379796Full text available |
| 11 |
Material Type: Article
|
|
Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple MyelomaThe New England journal of medicine, 2019-08, Vol.381 (8), p.727-738 [Peer Reviewed Journal]Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;Copyright © 2019 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1903455 ;PMID: 31433920Full text available |
| 12 |
Material Type: Article
|
|
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialBlood, 2020-08, Vol.136 (8), p.936-945 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 by The American Society of Hematology. ;2020 by The American Society of Hematology 2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020005288 ;PMID: 32325490Full text available |
| 13 |
Material Type: Article
|
|
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trialThe lancet oncology, 2014-10, Vol.15 (11), p.1195-1206 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 2014 ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(14)70440-1 ;PMID: 25242045 ;CODEN: LANCAOFull text available |
| 14 |
Material Type: Article
|
|
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialThe lancet oncology, 2020-12, Vol.21 (12), p.1630-1642 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30525-8 ;PMID: 33129376Full text available |
| 15 |
Material Type: Article
|
|
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12Journal of clinical oncology, 2014-11, Vol.32 (31), p.3490-3496 [Peer Reviewed Journal]2014 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2013.53.9593 ;PMID: 25267740Full text available |
| 16 |
Material Type: Article
|
|
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple MyelomaThe New England journal of medicine, 2015-01, Vol.372 (2), p.142-152 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1411321 ;PMID: 25482145Full text available |
| 17 |
Material Type: Article
|
|
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized TrialJAMA : the journal of the American Medical Association, 2021-11, Vol.326 (18), p.1807 [Peer Reviewed Journal]ISSN: 1538-3598 ;EISSN: 1538-3598 ;DOI: 10.1001/jama.2021.18295Digital Resources/Online E-Resources |
| 18 |
Material Type: Article
|
|
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trialThe lancet oncology, 2013-10, Vol.14 (11), p.1055-1066 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 2013 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(13)70380-2 ;PMID: 24007748 ;CODEN: LANCAOFull text available |
| 19 |
Material Type: Article
|
|
Bortezomib, Melphalan, and Dexamethasone for Light-Chain AmyloidosisJournal of clinical oncology, 2020-10, Vol.38 (28), p.3252-3260 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.01285 ;PMID: 32730181Full text available |
| 20 |
Material Type: Article
|
|
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaBlood, 2012-07, Vol.120 (1), p.9-19 [Peer Reviewed Journal]2012 American Society of Hematology ;2015 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2012-02-408898 ;PMID: 22498745Full text available |
Results 1 - 20 of 92,968 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (83,199)
Resource Type
- Articles (90,058)
- Book Chapters (1,355)
- magazinearticle (758)
- Reports (275)
- Patents (196)
- References (115)
- Newspaper Articles (59)
- Thesises (postgraduate) (57)
- Reviews (31)
- Conference Proceedings (26)
- Web Resources (15)
- Text Resources (13)
- Books (5)
- Newsletter Articles (4)
- Other (1)
-
More options
Subject
- Science & Technology (70,545)
- Life Sciences & Biomedicine (65,909)
- Humans (40,518)
- Male (24,688)
- Female (23,085)
- Animals (21,380)
- Biological And Medical Sciences (13,324)
- Middle Aged (12,589)
- Adult (12,448)
- Oncology (12,237)
- Medical Sciences (11,821)
- Patients (10,377)
- Aged (9,426)
- Medicine (9,181)
- Pharmacology & Pharmacy (9,155)
- Health Aspects (7,755)
- Review (7,653)
- Mice (7,652)
- Inflammation (7,613)
- Chemotherapy (7,471)
-
More options
Databases
- ProQuest Central (65,918)
- MEDLINE (54,341)
- PubMed (Medline) (38,976)
- Geneva Foundation Free Medical Journals at publisher websites (35,404)
- DOAJ Directory of Open Access Journals (34,593)
- ROAD: Directory of Open Access Scholarly Resources (28,224)
- HighWire Press (Free Journals) (6,449)
- SpringerOpen (6,319)
- Wiley Online Library Open Access (5,767)
- Nature (Open access) (4,794)
- ProQuest One Psychology (4,573)
- Coronavirus Research Database (4,222)
- Taylor & Francis Open Access (2,835)
- PLoS (Open access) (2,417)
- Dove Press Free (2,008)
- Medknow Medical Journals (Open access) (1,794)
- Journals@Ovid Open Access Journal Collection Rolling (1,515)
- IngentaConnect Backfiles (1,500)
- Sage Journals GOLD Open Access 2024 (1,404)
- Ebook Central - Academic Complete (1,287)
-
More options
Language
Journal Title
- Blood (783)
- Bone Marrow Transplantation (679)
- Cancers (706)
- International Journal Of Molecular Sciences (1,684)
- Pharmaceutics (641)
- Plos One (2,192)
- Reactions Weekly (2,400)
- Scientific Reports (1,036)
- The Journal Of Clinical Endocrinology And Metabolism (740)
- The New England Journal Of Medicine (789)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||